# Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation

> **NCT00057005** · PHASE1 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 6 (actual)

## Conditions studied

- LEUKEMIA

## Interventions

- **DRUG:** CAMPATH-1H
- **DRUG:** Anti-CD45
- **DRUG:** Ara-C
- **DRUG:** Cyclophosphamide
- **DRUG:** Mesna
- **RADIATION:** Total Body Irradiation

## Key facts

- **NCT ID:** NCT00057005
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00057005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00057005, "Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00057005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*